Lindberg A A, Segall T, Weintraub A, Stocker B A
Karolinska Institute, Department of Clinical Bacteriology, Huddinge Hospital, Sweden.
Infect Immun. 1993 Apr;61(4):1211-21. doi: 10.1128/iai.61.4.1211-1221.1993.
An auxotrophic Salmonella dublin (O9,12) strain, SL5631, with a deletion affecting gene aroA, was made into a partial diploid expressing the rfb (O-antigen-repeat-unit-specifying) gene cluster of Salmonella typhimurium (O4,12). By use of O4- and O9-specific antisera in indirect immunofluorescence assays, the resulting hybrid SL7103 was shown to express both the O4- and O9-antigen epitopes in the same bacterium. Qualitative and quantitative sugar analyses by gas-liquid chromatography on peralditol acetates of phenol-water-extracted lipopolysaccharides showed that the S. dublin and S. typhimurium repeating units (estimated on the basis of their tyvelose and abequose contents, respectively) were present in approximately equimolar amounts. The SL7103 hybrid auxotroph was avirulent when given intraperitoneally to NMRI mice in a dose of 10(8) CFU and elicited a protective immunity against intraperitoneal challenge with either virulent S. dublin (50% lethal dose of ca. 1.5 x 10(4) CFU versus < 1 x 10(1) CFU in nonimmunized mice) or virulent S. typhimurium (50% lethal dose of ca. 1 x 10(5) versus < 1 x 10(1) CFU in nonimmunized mice). Compared with the protection elicited in homologous systems (S. dublin SL5631 against S. dublin and S. typhimurium SL1479 against S. typhimurium), the protective efficacy of the hybrid was reduced approximately 70-fold against S. dublin challenge and 100-fold against S. typhimurium challenge. Vaccination with S. typhimurium SL1479 conferred no protection against S. dublin challenge, and vaccination with S. dublin SL5631 conferred no protection against S. typhimurium challenge. The protection elicited by the hybrid strain SL7103 is supposed to be mainly a consequence of serum antibodies directed against the immunodominant O4 and O9 epitopes.
一株营养缺陷型都柏林沙门氏菌(O9,12)菌株SL5631,其aroA基因存在缺失,被改造成部分二倍体,表达鼠伤寒沙门氏菌(O4,12)的rfb(O抗原重复单元指定)基因簇。通过在间接免疫荧光试验中使用O4和O9特异性抗血清,结果显示所得杂种SL7103在同一细菌中同时表达O4和O9抗原表位。通过气液色谱法对苯酚-水提取的脂多糖的过碘糖醇乙酸酯进行定性和定量糖分析表明,都柏林沙门氏菌和鼠伤寒沙门氏菌的重复单元(分别根据其泰威糖和阿比可糖含量估算)以大约等摩尔量存在。当以10⁸CFU的剂量腹腔注射给NMRI小鼠时,杂种营养缺陷型SL7103无毒,并对强毒都柏林沙门氏菌(免疫小鼠的50%致死剂量约为1.5×10⁴CFU,而未免疫小鼠中<1×10¹CFU)或强毒鼠伤寒沙门氏菌(免疫小鼠的50%致死剂量约为1×10⁵,而未免疫小鼠中<1×10¹CFU)的腹腔攻击引发保护性免疫。与同源系统(都柏林沙门氏菌SL5631针对都柏林沙门氏菌和鼠伤寒沙门氏菌SL1479针对鼠伤寒沙门氏菌)中引发的保护作用相比,该杂种对都柏林沙门氏菌攻击的保护效力降低了约70倍,对鼠伤寒沙门氏菌攻击的保护效力降低了100倍。用鼠伤寒沙门氏菌SL1479进行疫苗接种对都柏林沙门氏菌攻击没有保护作用,用都柏林沙门氏菌SL5631进行疫苗接种对鼠伤寒沙门氏菌攻击没有保护作用。杂种菌株SL7103引发的保护作用被认为主要是针对免疫显性O4和O9表位的血清抗体的结果。